— Know what they know.
Not Investment Advice

ALKEM.BO

Alkem Laboratories Limited
1W: +1.9% 1M: +0.8% 3M: -5.7% YTD: -5.8% 1Y: +7.4% 3Y: +87.1% 5Y: +88.7%
₹5,435.00 ($57.72)
+136.80 (+2.58%)
 
BSE · Healthcare · Drug Manufacturers - Specialty & Generic · ₹649.8B · Alpha Radar Neutral · Power 42
Smart Money Score
Watch 25
Insider
Congress
ETF Holdings
Key Statistics
Market Cap₹649.8B ($6.9B)
52W Range4627.9-5933
Volume1,992
Avg Volume21,683
Beta0.29
Dividend₹51.00
Analyst Ratings
No analyst coverage
Company Info
CEOVikas Gupta
Employees17,432
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date2015-12-23
Devashish Building
Mumbai 400013
IN
91 22 3982 9999
About Alkem Laboratories Limited

Alkem Laboratories Limited, a pharmaceutical company, engages in the development, manufacture, and sale of pharmaceutical and nutraceutical products in India and internationally. The company offers branded generics, generic drugs, active pharmaceutical ingredients, and biosimilars, and nutraceuticals in acute and chronic therapeutic areas comprising anti-infective, dermatology, cardiac, respiratory, gastro-intestinal, central nervous system, urology, and gynaecology, as well as vitamins, minerals, and nutrients; and pain analgesic, anti-diabetic, and neurology products. Alkem Laboratories Limited was incorporated in 1973 and is headquartered in Mumbai, India.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms